UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RTL
1326
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $3.49M | ﹤0.01% |
555,671
+39,651
| +8% | +$257K |
|
1327
Applovin
APP
$114B
| $3.49M | ﹤0.01% |
221,323
-70,106
| -24% | -$919K |
|
1328
Cactus
WHD
$5.68B
| $3.48M | ﹤0.01% |
84,425
+3,123
| +4% | +$151K |
|
1329
Patterson-UTI
PTEN
$4.18B
| $3.47M | ﹤0.01% |
296,512
-16,707
| -5% | -$244K |
|
1330
Steven Madden
SHOO
$3.56B
| $3.47M | ﹤0.01% |
96,304
+7,376
| +8% | +$256K |
|
1331
CNO Financial Group
CNO
$5.11B
| $3.45M | ﹤0.01% |
+155,330
| New | +$3.71M |
|
1332
First Interstate BancSystem
FIBK
$3.56B
| $3.44M | ﹤0.01% |
115,199
+5,861
| +5% | +$206K |
|
|
ETRN
1333
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $3.44M | ﹤0.01% |
595,073
+51,011
| +9% | +$327K |
|
|
SUM
1334
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $3.43M | ﹤0.01% |
120,496
+3,627
| +3% | +$110K |
|
|
CALY
1335
Callaway Golf Company
CALY
$3.07B
| $3.42M | ﹤0.01% |
158,313
+20,544
| +15% | +$466K |
|
1336
LCI Industries
LCII
$2.53B
| $3.42M | ﹤0.01% |
+31,113
| New | +$3.4M |
|
1337
Sprout Social
SPT
$608M
| $3.4M | ﹤0.01% |
55,851
+2,859
| +5% | +$175K |
|
1338
QuantumScape Corp
QS
$3.8B
| $3.38M | ﹤0.01% |
413,644
+55,992
| +16% | +$455K |
|
1339
Pacific Biosciences
PACB
$357M
| $3.37M | ﹤0.01% |
290,689
+14,693
| +5% | +$146K |
|
|
COOP
1340
DELISTED
Mr. Cooper
COOP
| $3.34M | ﹤0.01% |
+81,499
| New | +$3.57M |
|
|
AEL
1341
DELISTED
American Equity Investment Life Holding Company
AEL
| $3.32M | ﹤0.01% |
+91,020
| New | +$3.87M |
|
1342
Diageo
DEO
$53.7B
| $3.32M | ﹤0.01% |
18,328
+2,800
| +18% | +$494K |
|
1343
Brady Corp
BRC
$4.56B
| $3.31M | ﹤0.01% |
61,634
+803
| +1% | +$42K |
|
1344
Simply Good Foods
SMPL
$962M
| $3.3M | ﹤0.01% |
83,025
+4,320
| +5% | +$160K |
|
1345
Sociedad Química y Minera de Chile
SQM
$20.8B
| $3.3M | ﹤0.01% |
40,730
| – | – |
|
1346
Aaon
AAON
$7.38B
| $3.3M | ﹤0.01% |
+51,155
| New | +$2.81M |
|
|
OPI
1347
DELISTED
Office Properties Income Trust
OPI
| $3.3M | ﹤0.01% |
268,047
+21,151
| +9% | +$325K |
|
1348
First Bancorp
FBP
$4.4B
| $3.29M | ﹤0.01% |
288,529
+6,603
| +2% | +$86.9K |
|
|
INN
1349
Summit Hotel Properties
INN
$673M
| $3.29M | ﹤0.01% |
470,332
+13,124
| +3% | +$99.5K |
|
1350
Strategy Inc
MSTR
$37.6B
| $3.28M | ﹤0.01% |
112,070
+7,430
| +7% | +$181K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.